The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Mersana Therapeutics Inc’s stock clocked out at $1.99, up 1.53% from its previous closing price of $1.96. In other words, the price has increased by $1.53 from its previous closing price. On the day, 0.79 million shares were traded. MRSN stock price reached its highest trading level at $2.065 during the session, while it also had its lowest trading level at $1.945.
Ratios:
To gain a deeper understanding of MRSN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.72 and its Current Ratio is at 2.72. In the meantime, Its Debt-to-Equity ratio is 3.83 whereas as Long-Term Debt/Eq ratio is at 2.41.
On February 29, 2024, Wedbush Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $2 to $7.
Guggenheim Upgraded its Neutral to Buy on February 29, 2024, while the target price for the stock was maintained at $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 02 ’24 when DeSchuytner Brian sold 8,089 shares for $2.00 per share. The transaction valued at 16,178 led to the insider holds 100,422 shares of the business.
DeSchuytner Brian sold 5,598 shares of MRSN for $10,972 on Oct 03 ’24. The SVP, COO & CFO now owns 94,824 shares after completing the transaction at $1.96 per share. On Oct 02 ’24, another insider, Carvajal Alejandra, who serves as the SVP, Chief Legal Officer of the company, sold 8,089 shares for $2.00 each. As a result, the insider received 16,178 and left with 69,314 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRSN now has a Market Capitalization of 244123248 and an Enterprise Value of 114314352. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.15 while its Price-to-Book (P/B) ratio in mrq is 28.97. Its current Enterprise Value per Revenue stands at 3.818 whereas that against EBITDA is -1.127.
Stock Price History:
Over the past 52 weeks, MRSN has reached a high of $6.28, while it has fallen to a 52-week low of $1.07. The 50-Day Moving Average of the stock is 17.78%, while the 200-Day Moving Average is calculated to be -29.27%.
Shares Statistics:
It appears that MRSN traded 1.17M shares on average per day over the past three months and 1063070 shares per day over the past ten days. A total of 120.71M shares are outstanding, with a floating share count of 90.23M. Insiders hold about 26.45% of the company’s shares, while institutions hold 68.10% stake in the company. Shares short for MRSN as of 1726185600 were 10306527 with a Short Ratio of 8.78, compared to 1723680000 on 8487549. Therefore, it implies a Short% of Shares Outstanding of 10306527 and a Short% of Float of 11.05.
